SCHEMBL8938683

SCHEMBL8938683

O=c1[nH]ccc2cc(OCCCCC3CCCCC3)ccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 1/20 0.60
ROCK1 Q13464 12/20 0.50
ROCK2 O75116 2/20 0.50
PRKCD Q05655 2/20 0.50
PRKACA P17612 1/20 0.50
PRKG1 Q13976 1/20 0.50
PKN1 Q16512 1/20 0.50
PKN2 Q16513 1/20 0.50
AAK1 Q2M2I8 1/20 0.50
CDC42BPA Q5VT25 1/20 0.50
Q6ZSR9 Q6ZSR9 1/20 0.50
BMP2K Q9NSY1 1/20 0.50
CDC42BPB Q9Y5S2 1/20 0.50
HTR1A P08908 1/20 0.50
HTR1D P28221 1/20 0.50
HTR1B P28222 1/20 0.50
PTGES O14684 1/20 0.50
PRKX P51817 1/20 0.49
PRKCE Q02156 1/20 0.49
PRKD1 Q15139 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8938638 0.93 MAP2K1 (0.63) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL8934693 0.89 ROCK1 (0.61) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL8938523 0.85 MAP2K1 (0.76) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL8934691 0.82 ROCK1 (0.64) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL12851130 0.81 MAP2K1 (0.78) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL1038440 0.78 MAP2K1 (0.52) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL8935750 0.77 MAP2K1 (0.64) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL8938643 0.76 ROCK1 (0.58) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL8934682 0.75 MAP2K1 (1.00) MAP2K1ROCK1ROCK2PRKCDPRKACA
SCHEMBL8934670 0.75 MAP2K1 (1.00) MAP2K1ROCK1ROCK2PRKCDPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188117-B2 Piperidinyl-substituted isoquinolone derivatives SANOFI-AVENTIS (FR) 2012-05-29 US disclosed